# A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma

> **NCT06478264** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Zhangzhou Municipal Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Esophageal Small Cell Carcinoma

## Interventions

- **DRUG:** Etoposide
- **DRUG:** Cisplatin
- **DRUG:** Carboplatin
- **DRUG:** Adebrelimab
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT06478264
- **Lead sponsor:** Zhangzhou Municipal Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-13
- **Primary completion:** 2026-07-13
- **Final completion:** 2027-07-13
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06478264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06478264, "A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06478264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*